🏅 FDA Orphan Designation
Idelvion
recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP)
Manufacturer: CSL Behring, LLC
Indicated for:
Moderate hemophilia BOrphan
FDA-Approved Indications (1)
Moderate hemophilia BOrphan Designation
Indicated in children and adults with hemophilia B (congenital Factor IX deficiency) for the (1) on-demand control and prevention of bleeding episodes, (2) perioperative management of bleeding, and (3…
Indications & Usage
Indicated in children and adults with hemophilia B (congenital Factor IX deficiency) for the (1) on-demand control and prevention of bleeding episodes, (2) perioperative management of bleeding, and (3) routine prophylaxis to prevent or reduce the frequency of bleeding episodes.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.